XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Data (Tables) | 6 Months Ended
--- | ---
Jun. 28, 2025
Segment Data [Abstract] |
Business Segment Information | Three Months Ended Six Months Ended June 28, June 29, June 28, June 29, 2025 2024 2025 2024 Gross Sales: Global Distribution and Value -Added Services (1) $ 2,731 $ 2,654 $ 5,407 $ 5,347 Global Specialty Products (2) 386 370 753 730 Global Technology (3) 167 156 329 313 Total Gross Sales 3,284 3,180 6,489 6,390 Less: Eliminations: Global Distribution and Value -Added Services (4) (13) (8) (21) Global Specialty Products (40) (31) (73) (61) Global Technology - - - - Total Eliminations (44) (44) (81) (82) Net Sales Global Distribution and Value -Added Services 2,727 2,641 5,399 5,326 Global Specialty Products 346 339 680 669 Global Technology 167 156 329 313 Total Net Sales 3,240 3,136 6,408 6,308 Segment Cost of Sales (4) Global Distribution and Value -Added Services 2,043 1,953 4,038 3,939 Global Specialty Products 175 165 336 326 Global Technology 53 51 105 102 Total Segment Cost of Sales 2,271 2,169 4,479 4,367 Segment Operating Expenses (5) Global Distribution and Value -Added Services 529 525 1,043 1,061 Global Specialty Products 159 165 309 321 Global Technology 69 71 137 143 Total Segment Operating Expenses 757 761 1,489 1,525 Segment Operating Income Global Distribution and Value -Added Services 159 176 326 347 Global Specialty Products 52 40 108 83 Global Technology 45 34 87 68 Total Segment Operating Income 256 250 521 498 Corporate, net (31) (8) (66) (30) Adjustments (6) (74) (83) (129) (159) Total Operating Income $ 151 $ 159 $ 326 $ 309 Three Months Ended Six Months Ended June 28, June 29, June 28, June 29, 2025 2024 2025 2024 Depreciation and Amortization Global Distribution and Value -Added Services $ 36 $ 34 $ 71 $ 70 Global Specialty Products 29 28 56 53 Global Technology 11 12 22 24 Total Depreciation and Amortization $ 76 $ 74 $ 149 $ 147 Global Distribution and Value -Added Services: Includes distribution of infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, personal protective equipment (“PPE”) products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, high-tech and digital restoration equipment, equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting and other services. This segment also markets and sells under our own corporate brand a portfolio of cost-effective, high-quality consumable merchandise. (2) Global Specialty Products: Includes manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. (3) Global Technology: Includes development and distribution of practice management software, e-services and other products, which are distributed to health care providers. (4) Cost of goods sold in our Global Distribution and Value-Added Services segment and our Global Specialty Products segment includes product cost and inbound and outbound freight charges. Cost of goods sold in our Global Technology segment consists primarily of software development and third-party provider costs, including technology use and hosting fees. (5) Significant segment operating expenses for our reportable segments and Corporate include primarily compensation costs, and to a lesser extent, rent, depreciation and maintenance costs related to operating our facilities. Adjustments represent items excluded from segment operating income to enable comparison of financial results between periods. The following table presents a breakdown of such adjustments: Three Months Ended Six Months Ended June 28, June 29, June 28, June 29, 2025 2024 2025 2024 Adjustments: Restructuring costs $ (23) $ (15) $ (48) $ (25) Acquisition intangible amortization (44) (47) (87) (93) Cyber incident-insurance proceeds, net of third-party advisory expenses - 7 20 2 Change in contingent consideration - (23) 2 (38) Litigation settlements (1) (5) (1) (5) Impairment of intangible assets - - (1) - Costs associated with shareholder advisory matters and select value creation consulting costs (6) - (14) - Total adjustments $ (74) $ (83) $ (129) $ (159)

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration